Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME   >  CORPORATE INFO >  BOARD MEETINGS
Board Meetings      
Kerala Ayurveda Ltd.
Source DateBoard Meeting DateDetails
21-May-2025 26-May-2025 Audited Results
10-Feb-2025 14-Feb-2025 Quarterly Results
04-Dec-2024 09-Dec-2024 Preferential Issue of shares(Cancelled) (Cancelled) The Board Meeting to be held on 09/12/2024 Stands Cancelled.
11-Nov-2024 14-Nov-2024 Quarterly Results
07-Aug-2024 14-Aug-2024 Quarterly Results
23-May-2024 29-May-2024 Audited Results
06-Feb-2024 14-Feb-2024 Quarterly Results
21-Nov-2023 24-Nov-2023 Preferential Issue of shares Inter-alia, to consider the following matters: i. To consider a proposal for issuance of equity shares by way of a preferential allotment to investors (other than promoter & promoter group) in accordance with the provisions of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, The Companies Act, 2013, as amended, subject to such regulatory/ statutory approvals as may be required.; ii. To consider convening an extra-ordinary general meeting / postal ballot process to seek approval of the shareholders in respect of the aforesaid proposal of fund raising, as required.
07-Nov-2023 14-Nov-2023 Quarterly Results
28-Aug-2023 31-Aug-2023 Preferential Issue of shares
02-Aug-2023 10-Aug-2023 Quarterly Results
23-May-2023 30-May-2023 Quarterly Results
08-May-2023 11-May-2023 Preferential Issue of shares
06-Feb-2023 14-Feb-2023 Quarterly Results
07-Nov-2022 14-Nov-2022 Quarterly Results
04-Aug-2022 12-Aug-2022 Quarterly Results
23-Jun-2022 28-Jun-2022 Inter alia, to consider and approve Consideration and appointment of Independent Director
23-May-2022 30-May-2022 Quarterly Results & Audited Results
07-Feb-2022 14-Feb-2022 Quarterly Results
08-Nov-2021 12-Nov-2021 Quarterly Results
Page 1 of 6
Prev || Next
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.